Profile data is unavailable for this security.
About the company
Solasia Pharma K.K. is a Japan-based pharmaceutical company. The Company is mainly engaged in the development, sale, importing and exporting of pharmaceutical products targeting commercialization in Japan, China and other Asian countries. It focuses on commercializing assets in the oncology/hematology field, by developing products licensed from western pharmaceutical and biotech companies. The Company's main products include SP-01 Granisetron Transdermal Delivery System (Sancuso), SP-02 Darinaparsin (Zinapar, ZIO-101, and SP-03 Oral Medical Device (episil oral liquid).
- Revenue in JPY (TTM)617.00m
- Net income in JPY-1.11bn
- Incorporated2007
- Employees24.00
- LocationSolasia Pharma KK3F, Shiodome Bldg., 1-2-20, KaiganMINATO-KU 105-0011JapanJPN
- Phone+81 358438045
- Fax+81 367212020
- Websitehttps://solasia.co.jp/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perseus Proteomics Inc | 100.40m | -1.10bn | 3.80bn | 24.00 | -- | 2.63 | -- | 37.81 | -93.74 | -93.74 | 8.52 | 117.15 | 0.0471 | 3.35 | 8.55 | -- | -51.85 | -41.34 | -54.94 | -43.43 | 87.33 | 91.72 | -1,100.04 | -891.26 | 12.77 | -- | -- | -- | 6.58 | -18.31 | -40.34 | -- | 60.30 | -- |
| Kubota Pharmaceutical Holdings Co Ltd | 39.74m | -1.39bn | 3.88bn | 12.00 | -- | 1.66 | -- | 97.74 | -24.82 | -24.82 | 0.711 | 41.58 | 0.0118 | 0.3815 | 26.89 | 3,312,000.00 | -41.32 | -36.51 | -45.53 | -39.47 | 72.88 | -- | -3,492.38 | -13,528.87 | 8.97 | -- | 0.0555 | -- | 383.24 | -- | 26.11 | -- | 24.38 | -- |
| Human Metabolome Technologies Inc | 1.32bn | 282.64m | 3.90bn | 57.00 | 13.78 | 2.20 | 10.69 | 2.95 | 47.83 | 47.83 | 223.67 | 299.17 | 0.6302 | 14.23 | 4.74 | 23,186,330.00 | 13.48 | -- | 16.73 | -- | 65.03 | -- | 21.39 | -- | 4.27 | 151.90 | 0.1103 | -- | 6.21 | -- | 6.71 | -- | -- | -- |
| FunPep Co Ltd | 676.00k | -760.40m | 4.16bn | 15.00 | -- | 1.77 | -- | 6,155.93 | -31.52 | -31.52 | 0.028 | 90.56 | 0.0002 | -- | 3.39 | 45,066.67 | -26.86 | -27.10 | -28.42 | -28.75 | -- | -- | -112,484.90 | -815.82 | 17.27 | -1,006.15 | 0.00 | -- | -50.33 | -72.80 | 20.39 | -- | -13.14 | -- |
| BrightPath Biotherapeutics Co Ltd | 72.00k | -1.17bn | 4.19bn | 32.00 | -- | 4.26 | -- | 58,132.45 | -18.30 | -18.30 | 0.0011 | 13.84 | 0.00005 | -- | 2.36 | -- | -79.69 | -51.56 | -87.69 | -54.32 | 75.00 | 68.63 | -1,622,336.00 | -22,321.82 | -- | -435.39 | 0.1031 | -- | -98.64 | -78.47 | 21.37 | -- | -46.55 | -- |
| Kringle Pharma Inc | 77.93m | -904.81m | 4.27bn | 13.00 | -- | 1.82 | -- | 54.82 | -159.92 | -159.92 | 13.58 | 356.64 | 0.027 | -- | 2.80 | 5,994,308.00 | -31.29 | -19.00 | -33.20 | -20.23 | -- | -- | -1,161.12 | -156.51 | 12.85 | -- | -- | -- | -82.33 | -- | -157.41 | -- | -- | -- |
| Renascience Inc | 194.17m | -258.34m | 4.56bn | 3.00 | -- | 2.84 | -- | 23.50 | -20.32 | -20.32 | 15.27 | 126.40 | 0.089 | -- | -- | -- | -11.84 | -- | -12.49 | -- | 85.31 | -- | -133.05 | -- | -- | -- | 0.1814 | -- | 93.11 | -- | 23.07 | -- | -- | -- |
| Immuno-Biological Laboratories Co., Ltd. | 816.70m | 186.69m | 4.69bn | 60.00 | 25.09 | 3.70 | -- | 5.74 | 20.05 | 20.05 | 87.69 | 135.86 | 0.535 | 0.9358 | 4.53 | -- | 12.23 | -13.97 | 14.68 | -16.39 | 63.34 | 57.73 | 22.86 | -39.23 | 3.65 | -- | 0.1572 | -- | 2.78 | 0.8924 | 164.44 | -- | -- | -- |
| Delta-Fly Pharma Inc | 0.00 | -1.26bn | 4.84bn | 11.00 | -- | 2.86 | -- | -- | -187.93 | -187.93 | 0.00 | 205.25 | 0.00 | -- | -- | 0.00 | -92.45 | -53.35 | -103.56 | -55.60 | -- | -- | -- | -769.75 | -- | -391.17 | 0.00 | -- | -100.00 | -- | -37.37 | -- | -- | -- |
| Solasia Pharma KK | 617.00m | -1.11bn | 5.03bn | 24.00 | -- | 2.41 | -- | 8.15 | -6.61 | -6.61 | 3.67 | 10.78 | 0.2301 | 4.10 | 1.93 | 25,708,330.00 | -41.51 | -48.57 | -47.74 | -58.83 | 54.78 | 71.01 | -180.39 | -300.89 | 2.91 | -- | 0.031 | -- | -43.50 | 14.18 | 56.36 | -- | -- | -- |
| Kidswell Bio Corp | 2.43bn | -1.42bn | 5.12bn | 41.00 | -- | 6.09 | -- | 2.11 | -40.81 | -40.81 | 68.79 | 21.35 | 0.5415 | 1.84 | 2.47 | -- | -31.67 | -57.41 | -51.25 | -81.13 | 42.75 | 55.20 | -58.49 | -123.52 | 1.70 | -28.91 | 0.7559 | -- | -12.43 | 18.93 | -116.31 | -- | -- | -- |
| KAINOS Laboratories, Inc. | 5.06bn | 637.97m | 5.23bn | 144.00 | 7.53 | 0.7723 | 6.92 | 1.04 | 152.41 | 152.41 | 1,206.78 | 1,486.43 | 0.6053 | 3.08 | 4.55 | -- | 7.64 | 6.92 | 9.96 | 9.26 | 50.46 | 51.84 | 12.62 | 10.80 | 2.43 | -- | 0.1221 | 18.46 | 2.71 | 1.60 | 12.28 | 10.57 | -9.83 | 16.36 |
| Cyfuse Biomedical KK | 64.79m | -645.40m | 5.95bn | 21.00 | -- | 1.93 | -- | 91.81 | -82.27 | -82.27 | 8.26 | 378.39 | 0.0153 | 0.5202 | 13.80 | 3,085,095.00 | -15.19 | -- | -17.68 | -- | 61.81 | -- | -996.19 | -- | 6.39 | -81.61 | 0.2126 | -- | -83.68 | -- | -24.32 | -- | -- | -- |
| Noile-Immune Biotech Inc | 311.30m | -975.80m | 6.37bn | 28.00 | -- | 1.19 | -- | 20.45 | -22.56 | -22.56 | 7.19 | 123.55 | 0.0658 | 0.139 | 5.07 | 11,118,000.00 | -20.62 | -- | -21.29 | -- | 99.55 | -- | -313.45 | -- | 52.74 | -805.65 | 0.00 | -- | -49.37 | -- | -192.28 | -- | -- | -- |
| MEDRx Co Ltd | 22.57m | -770.66m | 6.37bn | 22.00 | -- | 3.03 | -- | 282.31 | -20.97 | -20.97 | 0.6128 | 47.84 | 0.0143 | 0.00 | 4.22 | 1,025,955.00 | -48.80 | -58.15 | -50.27 | -62.23 | 100.00 | 95.70 | -3,414.38 | -1,526.17 | 43.57 | -- | 0.00 | -- | -50.35 | 28.60 | 16.04 | -- | -55.29 | -- |
| DNA Chip Research Inc | 490.46m | -248.29m | 6.44bn | 36.00 | -- | 8.78 | -- | 13.12 | -39.09 | -39.09 | 77.17 | 108.27 | 0.5292 | 9.84 | 3.11 | -- | -26.79 | -23.49 | -32.60 | -26.70 | 13.53 | 14.28 | -50.62 | -54.10 | 2.92 | -2,206.97 | -- | -- | 49.74 | 6.33 | 31.48 | -- | -15.75 | -- |
Data as of May 20 2024. Currency figures normalised to Solasia Pharma KK's reporting currency: Japanese Yen JPY
1.58%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rheos Capital Works, Inc. (Investment Management)as of 30 Sep 2022 | 2.32m | 1.20% |
| Simplex Asset Management Co., Ltd.as of 09 May 2024 | 718.30k | 0.37% |
Data from 31 Mar 2024 - 09 May 2024Source: FactSet Research Systems Inc.
